Spiro Pavlopoulos1, Dimitrios N Pelekoudas2, Othman Benchama2, Catherine M Rawlins3, Jeffrey N Agar4, Jay M West2, Michael Malamas2, Nikolai Zvonok2, Alexandros Makriyannis5. 1. Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States. Electronic address: s.pavlopoulos@northeastern.edu. 2. Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States. 3. Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, MA, 02115-5000, United States. 4. Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, MA, 02115-5000, United States; Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States. 5. Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States; King Abdulaziz University, Jeddah, 22254, Saudi Arabia.
Abstract
N-acylethanolamine acid amidase (NAAA) is an N-terminal nucleophile (Ntn) enzyme with a catalytic cysteine residue that has highest activity at acidic pH. The most prominent substrate hydrolyzed is palmitoylethanolamine (PEA), which regulates inflammation. Inhibitors of NAAA have been shown to increase endogenous levels of PEA, and are of interest as potential treatments for inflammatory disorders and other maladies. Currently, there are no X-ray or NMR structures of NAAA available to inform medicinal chemistry. Additionally, there are a limited number of enzyme structures available that are within the Ntn-hydrolase family, have a catalytic cysteine residue, and have a high sequence homology. For these reasons, we developed expression and purification methods for the production of enzyme samples amenable to structural characterization. Mammalian cells are necessary for post-translational processing, including signal sequence cleavage and glycosylation, that are required for a correctly folded zymogen before conversion to active, and mature enzyme. We have identified an expression construct, mammalian cell line, specific media and additives to express and secrete hNAAA zymogen and we further optimized propagation conditions and show this secretion method is suitable for isotopic labeling of the protein. We refined purification methods to achieve a high degree of protein purity potentially suited to crystallography. Glycosylated proteins can present challenges to biophysical methods. Therefore we deglycosylate the enzyme and show that the activity of the mature enzyme is not affected by deglycosylation. Published by Elsevier Inc.
pan class="Gene">N-acylethanolamine acid amidase (n>an class="Gene">NAAA) is an N-terminal nucleophile (Ntn) enzyme with a catalytic cysteine residue that has highest activity at acidic pH. The most prominent substrate hydrolyzed is palmitoylethanolamine (PEA), which regulates inflammation. Inhibitors of NAAA have been shown to increase endogenous levels of PEA, and are of interest as potential treatments for inflammatory disorders and other maladies. Currently, there are no X-ray or NMR structures of NAAA available to inform medicinal chemistry. Additionally, there are a limited number of enzyme structures available that are within the Ntn-hydrolase family, have a catalytic cysteine residue, and have a high sequence homology. For these reasons, we developed expression and purification methods for the production of enzyme samples amenable to structural characterization. Mammalian cells are necessary for post-translational processing, including signal sequence cleavage and glycosylation, that are required for a correctly folded zymogen before conversion to active, and mature enzyme. We have identified an expression construct, mammalian cell line, specific media and additives to express and secrete hNAAA zymogen and we further optimized propagation conditions and show this secretion method is suitable for isotopic labeling of the protein. We refined purification methods to achieve a high degree of protein purity potentially suited to crystallography. Glycosylated proteins can present challenges to biophysical methods. Therefore we deglycosylate the enzyme and show that the activity of the mature enzyme is not affected by deglycosylation. Published by Elsevier Inc.
Authors: Jay M West; Nikolai Zvonok; Kyle M Whitten; Jodianne T Wood; Alexandros Makriyannis Journal: J Proteome Res Date: 2012-01-03 Impact factor: 4.466
Authors: Patricia C Schmid; Lester E Wold; Randy J Krebsbach; Evgueni V Berdyshev; Harald H O Schmid Journal: Lipids Date: 2002-09 Impact factor: 1.880
Authors: Jesse Lo Verme; Jin Fu; Giuseppe Astarita; Giovanna La Rana; Roberto Russo; Antonio Calignano; Daniele Piomelli Journal: Mol Pharmacol Date: 2004-10-01 Impact factor: 4.436
Authors: Jay M West; Nikolai Zvonok; Kyle M Whitten; Subramanian K Vadivel; Anna L Bowman; Alexandros Makriyannis Journal: PLoS One Date: 2012-08-31 Impact factor: 3.240